Aion Diagnostics Lists on Frankfurt Stock Exchange, separating it from failing parent pSivida

April 23, 2007 | Analyst Insight

Last week, Aion Diagnostics, the medical-imaging subsidiary of Australian drug delivery firm pSivida, announced that it had been acquired by GEM Global Yield fund in conjunction with its listing on...

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978